APO-DIGOXIN 0.125 MG
DIGOXIN : 0.125 MG · DIN 02281228 · APOTEX INC
Health Canada status: DORMANT
What is APO-DIGOXIN?
APO-DIGOXIN 0.125 MG contains DIGOXIN : 0.125 MG. It is listed in the Health Canada Drug Product Database under DIN 02281228, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 04-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02281228 |
|---|---|
| Brand name | APO-DIGOXIN |
| Generic / active ingredient | DIGOXIN : 0.125 MG |
| Manufacturer | APOTEX INC |
| Strength | 0.125 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C01AA05 DIGOXIN |
| AHFS class | 24:04.08 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 04-Aug-2017 |
| Original market date | 2006-06-22 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C01AA05 DIGOXIN. 8 of 32 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-DIGOXIN | 0.0625 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02554399 |
| AURO-DIGOXIN | 0.125 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02554402 |
| DIGOXIN INJECTION C.S.D. | 0.5 MG / 2 ML | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02048264 |
| JAMP DIGOXIN | 0.0625 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02498502 |
| JAMP DIGOXIN | 0.125 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02498510 |
| PMS-DIGOXIN | 0.05 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | DIN 02242320 |
| PMS-DIGOXIN | 0.0625 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02335700 |
| PMS-DIGOXIN | 0.125 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02335719 |
| APO-DIGOXIN | 0.0625 MG | TABLET | APOTEX INC | DORMANT | DIN 02281236 |
| APO-DIGOXIN | 0.25 MG | TABLET | APOTEX INC | DORMANT | DIN 02281201 |
Who else supplies DIGOXIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DIGOXIN appears in 52 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.